GHB

Routes
Oral (PO)
Half-Life (t½)
PO: 31m
Formula
C4H8O3
Molecular Weight
104.1 g/mol
PubChem CID
10413
Aliases
gamma-hydroxybutyrate, sodium oxybate, Xyrem, G

Pharmacological Mechanism

γ-hydroxybutyrate, an endogenous GABA metabolite; an agonist at GABA-B and at specific high-affinity GHB receptors, producing CNS depression, euphoria, and (marketed) anabolic/sleep effects. Very narrow margin between recreational sedation and coma/respiratory depression. Medical form is sodium oxybate (Xyrem) for narcolepsy/cataplexy.

Half-Life & Elimination Curve (PO: 31m)

100%50%25%12.5%0%0h0×t½31m1×t½1.02h2×t½1.53h3×t½2.04h4×t½2.55h5×t½0×t½ (0h): 100% remaining1×t½ (31m): 50% remaining2×t½ (1.02h): 25% remaining3×t½ (1.53h): 12.5% remaining4×t½ (2.04h): 6.3% remaining5×t½ (2.55h): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½31m50%
  • 2×t½1.02h25%
  • 3×t½1.53h12.5%
  • 4×t½2.04h6.3%
  • 5×t½2.55h3.1%
Elimination t½31m (PO)
Rate Constant (ke)1.36 h⁻¹
97% Washout (5×t½)2.55h

Dosing Guidelines

Target Organ Systems

Notes

PubChem CID 10413. PK: Brenneisen 2004 (PMID:15538955) verbatim "The terminal plasma elimination half-life was 30.4 +/- 2.45 min" after a single oral 25 mg/kg dose in 8 healthy volunteers (=0.51 h). GABA-B occupancy deferred.

Chemical Structure & Identifiers

References